LD-2 disclosure · 3rd Quarter - Report
AMNEAL PHARMACEUTICALS
Expenses$310Kself-filed spend
Client
- Description
- Pharmaceutical company
- Location
- New Jersey · United States of America
Registrant
- Location
- Bridgewater, New Jersey, United States of America
Lobbying activities
1 issueHealth Issues
Addressing drug shortages and enhancing domestic production of critical medicines Issues and proposed legislation related to long-term sustainability of access for patients to generic and biosimilar medicines, including but not limited to pharmaceutical supply chain security, drug shortages, biosimilar interchangeability, and PBM reform Issues related to Medicaid Generics Penalty Issues related to possible drug shortage of levothyroxine capsules Issues related to tariffs Appropriations for increasing domestic manufacturing of generic medicines Issues related to NDAA
LobbyistsJULIAN MALASI
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office